1. Home
  2. ATLO vs TLSI Comparison

ATLO vs TLSI Comparison

Compare ATLO & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$27.04

Market Cap

239.2M

Sector

Finance

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$3.88

Market Cap

267.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
TLSI
Founded
1903
2010
Country
United States
United States
Employees
260
110
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.2M
267.1M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
ATLO
TLSI
Price
$27.04
$3.88
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
33.1K
218.2K
Earning Date
04-16-2026
03-05-2026
Dividend Yield
3.04%
N/A
EPS Growth
8.03
N/A
EPS
0.38
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$41.93
Revenue Next Year
N/A
$41.75
P/E Ratio
$69.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.09
$3.42
52 Week High
$28.35
$7.95

Technical Indicators

Market Signals
Indicator
ATLO
TLSI
Relative Strength Index (RSI) 52.18 30.16
Support Level $25.95 $3.79
Resistance Level $28.28 $5.51
Average True Range (ATR) 0.75 0.30
MACD -0.12 -0.07
Stochastic Oscillator 61.49 8.42

Price Performance

Historical Comparison
ATLO
TLSI

About ATLO Ames National Corporation

Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Share on Social Networks: